My wife has been using Mounjaro, generically known as tirzepatide, is an injectable medication initially approved by the U.S. Food and Drug Administration (FDA) in May 2022 for the treatment of type 2 diabetes. She does not have diabetes but has struggled with weight for most of her adult life. She has lost about 35 pounds and … Continue reading →